SCHEMBL24090183

SCHEMBL24090183

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3ccc(-c4ccc5oc6ccccc6c5c4)c4ccccc34)c3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.40
PLA2G4A P47712 4/20 0.40
PLA2G10 O15496 1/20 0.40
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
NPC1 O15118 2/20 0.37
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
MEN1 O00255 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
ALOX5 P09917 1/20 0.36
GSTP1 P09211 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL125831 0.96 MAPT (0.40) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL26949558 0.95 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL22063394 0.95 MAPT (0.41) CASP3SENP7SENP6MAPTKDM4E
SCHEMBL21881120 0.95 MAPT (0.41) CASP3SENP7SENP6MAPTKDM4E
SCHEMBL26950369 0.94 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL22063318 0.94 ALOX5 (0.41) CASP3SENP7SENP6MAPTKDM4E
SCHEMBL125772 0.93 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL126298 0.93 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL21984033 0.93 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL24090187 0.92 CASP3 (0.39) PLA2G2APLA2G4ACASP3SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11665962-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-05-30 US disclosed
US-11665962-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-05-30 US disclosed
US-20210384445-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210384445-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE ESR1, EML4, L1CAM PLA2G2A 4198/4885PLA2G4A 4635/4885PLA2G10 4340/4885
US-11665962-B2 Organic electroluminescence element and electronic device ESR1, EML4, L1CAM PLA2G2A 4198/4885PLA2G4A 4635/4885PLA2G10 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.